AlphAIalphai — Financial news for AI agents
finance.yahoo.comJUN 14 min read$ACHC

Buckley Capital’s Insights on Acadia Healthcare (ACHC)

Buckley Capital Advisors’ Q1 2026 investor letter said small/mid-cap equities were difficult early in 2026, but its portfolio improved in April (+13.8% net month-to-date, +8.6% net year-to-date) and continued into May. The letter cited Acadia Healthcare (NASDAQ:ACHC), which closed May 29 at $23.20 (market cap $2.13B). Buckley said it trimmed ACHC at current prices after it became a top contributor, citing CEO Debra “Debbie” Osteen’s reappointment.

Original reporting
finance.yahoo.com
Published Jun 1, 2026, 3:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 1, 2026, 3:57 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Buckley Capital’s Insights on Acadia Healthcare (ACHC) — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$ACHCBullishLow
01

Why it matters

The piece may influence positioning/sentiment among value-focused investors due to CEO-reappointment narrative, but it does not introduce new ACHC financial or regulatory information.

02

Market read

Single-stock investor-letter spotlight on ACHC with a leadership narrative; limited incremental trading signal versus company fundamentals.

03

What to watch

No details are provided on ACHC’s current fundamentals, guidance, or operating metrics; the CEO reappointment is framed, not evidenced with new performance data.

Relevance 6/10Novelty 2/10Timing: Published today; no new ACHC event tied to the timestamp beyond investor-letter commentary.

Background

Buckley Capital released its Q1 2026 investor letter, describing small/mid-cap headwinds early in the quarter and improved performance in April/May, with ACHC highlighted as a core holding.

Company-level read

Ticker impact

$ACHCBullishMedium confidence
Context

Buckley Capital’s Q1 2026 letter names Acadia Healthcare as its largest contributor and says it is trimming at current prices after CEO reappointment.

Expected impact

Near-term impact likely limited; could support sentiment among value/special-situations investors, but it’s not a new company fundamental catalyst.

Evidence & confidence

This is primarily commentary from an investor letter with no new earnings, guidance, or operational disclosure; the only company-specific “fresh” element is the CEO reappointment framing and the manager’s trimming behavior.

Market effects

Sector

Behavioral health operators may see incremental sentiment support when credible leadership changes are highlighted, but no sector-wide new data is provided.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Investor-letter enthusiasm and trimming at “today’s prices” can be read as caution that upside may already be priced, especially after a strong run.

Key entities

  • public_company
    Acadia Healthcare Company, Inc.

    Behavioral health services provider; subject of the investor-letter discussion and CEO reappointment catalyst framing.

  • person
    Debra “Debbie” Osteen

    Named as reappointed CEO; described as a long-tenured behavioral health operator at Universal Health Services.

  • investment_firm
    Buckley Capital Advisors

    Author of the investor letter highlighting ACHC as a top contributor and noting trimming at current prices.

Read at source← All news

Related articles

JUL 30
$ACHCMedAI 8/10

Acadia Healthcare Q2 Earnings Call Highlights

Acute care: Revenue was $495 million, flat year over year but up 6% after normalizing for supplemental payments. Management cited strong volumes and admissions at existing acute facilities as well as newer joint-venture and de novo locations. Specialty care: Revenue was $134 million, up 4% sequentially from the first quarter. The business experienced the full-quarter impact of the New York Medicaid decision.

yahoo.com6 min
JUL 28
$ACHCMedAI 8/10

Acadia Healthcare: Q2 Earnings Snapshot

Acadia Healthcare Co. (ACHC) reported Q2 net income of 12 cents per share and adjusted earnings of 38 cents per share, versus a Zacks mean estimate of 33 cents. Revenue was $865.8 million, above the $844.7 million forecast. Full-year guidance calls for EPS of $1.45 to $1.60 and revenue of $3.4 billion to $3.45 billion.

local3news.com2 min
JUL 28
$ACHCMed

Acadia Healthcare (NASDAQ:ACHC) Posts Better

Acadia Healthcare (NASDAQ:ACHC) reported Q2 CY2026 revenue of $865.8 million, flat year on year but above expectations by about 2%, and non-GAAP adjusted EPS of $0.38, down from $0.83 but 9.7% above consensus. The company guided full-year revenue to about $3.43 billion. Shares fell about 1.3% to $32.18 after the report.

financialcontent.com6 min
JUL 28
$ACHCMed

Acadia Healthcare Company, Inc. (ACHC): Results of Operations and Financial Condition

Acadia Healthcare Company, Inc. (ACHC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_994474.htm EXHIBIT 99.1 ex_994474.htm Exhibit 99.1 ACADIA HEALTHCARE ANNOUNCES SECOND QUARTER 2026 RESULTS AND UPDATES FULL YEAR 2026 FINANCIAL AND CASH FLOW GUIDANCE FRANKLIN, Tenn. (July 28, 2026 ) – Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASD

SEC EDGAR 8-K4 min